Under Armour Crumbles After Guidance Miss, Street Cuts Targets

The Street reaction to the print was rapid and one-directional. Five firms cut price targets on the same day, all within hours of each other. Stifel was the most notable mover — the only outright downgrade in the batch, dropping from Buy to Hold while cutting its target from $9 to $6. Citi, maintaining its Sell rating, set the most bearish marker at $4.75. BNP Paribas, Truist, and Barclays all trimmed to $5, while holding neutral-to-hold ratings. The consensus price target mean has now been revised down to $6.54, which sits just 30% above the current price. Given the pace at which targets have been cut, that gap may narrow further in coming days. The valuation picture is complicated: the trailing P/E has actually expanded sharply on the week to 26x, a mechanical result of the stock declining faster than earnings estimates, and EV/EBITDA has risen to 12.7x. Neither multiple looks attractive on a growth-adjusted basis, particularly with forward EPS growth expected to be modest. Factor scores reflect the contradictions clearly — EPS surprise ranks in the 100th percentile, suggesting the company has consistently beaten backward-looking estimates, yet the forward picture is ugly enough to trigger a wave of target cuts.

The institutional structure provides an unusual backstop. Fairfax Financial, through Hamblin Watsa Investment Counsel, holds 15.3% of outstanding shares and added aggressively through December 2025 and January 2026 at prices between $4.50 and $6.30 — well below the levels that now look like the ceiling. Founder Kevin Plank holds another 13.1%. Together, those two alone account for more than 28% of shares outstanding. That concentration limits the actual float available for short sellers and creates a structural floor of committed, long-term holders. BlackRock added 7.5 million shares as recently as April 30, bringing its stake to 8.8%. Vanguard added 2.6 million in Q1. These passive and near-passive inflows offer no immediate price signal, but they do suggest the register is not uniformly bearish at the institutional level.

The one genuinely positive reference point in the data is the prior earnings cycle. When UAA reported in February 2026, the stock jumped 25% on the day and delivered a 14% gain over the following five days. That move came after a print that beat consensus on operating metrics. The current setup is the inverse: guidance revised lower, targets slashed, and sentiment firmly negative. What the February reaction showed is that the short base is large enough that any credible evidence of stabilisation can generate a violent short-covering move. That dynamic has not been triggered this week — it may not be for some time — but it frames the risk on both sides. The official FINRA settlement data through April 30 pegged short interest at 42.2 million shares with 5.8 days to cover, consistent with the ORTEX estimate.

With Q1 earnings now officially in the market and results absorbed, the next focus is FY27 guidance framing. The company's commentary around tariff pass-through, the wind-down of the Curry brand, and any update on its direct-to-consumer trajectory will determine whether the current target cluster around $5–$6 holds or gives way. Peers COLM and VFC fell 3.1% and 4.0% on the week respectively — weak, but nowhere near UAA's 20% drawdown — underlining how much of this week's move was specific to Under Armour's own execution rather than a sector-wide rotation.